Meningococcal vaccine approved for infants

SBS

11 September 2017 - A vaccine that protects very young children against four strains of meningococcal has been approved by the TGA.

A combination vaccine that protects against four strains of potentially deadly meningococcal disease has been approved for use in young infants in Australia.

Vaccine Menveo provides immunity to strains A, C, W and Y and was approved for use in babies from the age of two months by the TGA, GSK announced on Tuesday.

Read SBS News article

Michael Wonder

Posted by:

Michael Wonder